These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


229 related items for PubMed ID: 34077777

  • 1. The VDR gene confers a genetic predisposition to Graves' disease and Graves' ophthalmopathy in the Southwest Chinese Han population.
    Zhou F, Liang Z, Wang X, Tan G, Wei W, Zheng G, Ma X, Tian D, Li H, Yu H.
    Gene; 2021 Aug 15; 793():145750. PubMed ID: 34077777
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. TNFSF15 Polymorphisms are Associated with Graves' Disease and Graves' Ophthalmopathy in a Han Chinese Population.
    Zhang M, Liu S, Xu J, Lv S, Fan Y, Zhang Y, Zhang Y, Wu Y, Su Y, Yu H, Song S, He J, Li H.
    Curr Eye Res; 2020 Jul 15; 45(7):888-895. PubMed ID: 31869260
    [Abstract] [Full Text] [Related]

  • 4. The Role of FOXP3 Polymorphisms in Graves' Disease with or without Ophthalmopathy in a Turkish Population.
    Yaylacıoğlu Tuncay F, Serbest Ceylanoğlu K, Güntekin Ergün S, Ergün G, Konuk O.
    Turk J Ophthalmol; 2024 Apr 19; 54(2):69-75. PubMed ID: 38645270
    [Abstract] [Full Text] [Related]

  • 5. Lack of association of interleukin-18 gene polymorphisms with susceptibility of Japanese populations to Graves' disease or Graves' ophthalmopathy.
    Mukai T, Hiromatsu Y, Ichimura M, Fukutani T, Kaku H, Miyake I, Shoji S, Koda Y, Bednarczuk T.
    Thyroid; 2006 Mar 19; 16(3):243-8. PubMed ID: 16571086
    [Abstract] [Full Text] [Related]

  • 6. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
    Yin X, Latif R, Bahn R, Tomer Y, Davies TF.
    Thyroid; 2008 Nov 19; 18(11):1201-6. PubMed ID: 18925838
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population.
    Ichimura M, Kaku H, Fukutani T, Koga H, Mukai T, Miyake I, Yamada K, Koda Y, Hiromatsu Y.
    Thyroid; 2008 Jun 19; 18(6):625-30. PubMed ID: 18578611
    [Abstract] [Full Text] [Related]

  • 9. Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population.
    Ban Y, Taniyama M, Ban Y.
    J Clin Endocrinol Metab; 2000 Dec 19; 85(12):4639-43. PubMed ID: 11134121
    [Abstract] [Full Text] [Related]

  • 10. The common -318C/T polymorphism in the promoter region of CTLA4 gene is associated with reduced risk of ophthalmopathy in Chinese Graves' patients.
    Han SZ, Zhang SH, Li R, Zhang WY, Li Y.
    Int J Immunogenet; 2006 Aug 19; 33(4):281-7. PubMed ID: 16893393
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients.
    Esteghamati A, Khalilzadeh O, Mobarra Z, Anvari M, Tahvildari M, Amiri HM, Rashidi A, Solgi G, Parivar K, Nikbin B, Amirzargar A.
    Eur J Intern Med; 2009 Jul 19; 20(4):424-8. PubMed ID: 19524188
    [Abstract] [Full Text] [Related]

  • 14. Association between vitamin-D receptor gene FokI polymorphism and Graves' disease among Taiwanese Chinese.
    Chen RH, Chang CT, Chen HY, Chen WC, Tsai CH, Tsai FJ.
    J Clin Lab Anal; 2007 Jul 19; 21(3):173-7. PubMed ID: 17506475
    [Abstract] [Full Text] [Related]

  • 15. The functional polymorphisms of VDR, GC and CYP2R1 are involved in the pathogenesis of autoimmune thyroid diseases.
    Inoue N, Watanabe M, Ishido N, Katsumata Y, Kagawa T, Hidaka Y, Iwatani Y.
    Clin Exp Immunol; 2014 Nov 19; 178(2):262-9. PubMed ID: 25046415
    [Abstract] [Full Text] [Related]

  • 16. Poly (ADP-ribose) polymerase-1 (PARP-1) in Chinese patients with Graves' disease and Graves' ophthalmopathy.
    Wu T, Tang DR, Zhao L, Sun FY.
    Can J Physiol Pharmacol; 2018 Jun 19; 96(6):556-561. PubMed ID: 28177666
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.